Intermolecular (NASDAQ:IMI) with $3 Target Got Coverage By Lake Street On Jun 29, 2018.

June 29, 2018 - By Ronnie Lemelle

Intermolecular, Inc. (NASDAQ:IMI) Corporate Logo

During Q1 2018 the big money sentiment increased to 1.44. That’s change of 0.06, from 2017Q4’s 1.38. 5 investors sold all, 4 reduced holdings as Intermolecular, Inc. ratio is positive. 5 rose stakes while 8 funds acquired stakes. Funds hold 18.13 million shares thus 2.02% less from 2017Q4’s 18.50 million shares.

Rbf Limited Liability Company invested 0.01% of its capital in Intermolecular, Inc. (NASDAQ:IMI). Raging Cap Limited Liability Company reported 14.73 million shs or 2.57% of all its holdings. Northern, a Illinois-based fund reported 31,697 shs. Moreover, Geode Mgmt Ltd has 0% invested in Intermolecular, Inc. (NASDAQ:IMI) for 69,386 shs. Deutsche Bancorp Ag reported 75,184 shs stake. Horizon Kinetics Ltd Co reported 0% stake. Citadel Advisors Limited Liability Company accumulated 0% or 13,038 shs. Bridgeway Management Inc stated it has 260,700 shs or 0% of all its holdings. Symmetry Peak Management Ltd Limited Liability Company has 355,666 shs for 0.13% of their capital. Vanguard Grp Incorporated reported 0% stake. Ingalls & Snyder Ltd Liability Corporation owns 26,500 shs or 0% of their US capital. Blackrock Incorporated holds 0% or 71,525 shs. Thompson Siegel & Walmsley Limited accumulated 2,400 shs. Tower Capital Ltd Liability Corp (Trc), a New York-based fund reported 1,350 shs. Essex Inv Management Ltd Liability owns 153,485 shs.

What Price Target Has Lake Street Given Intermolecular (NASDAQ:IMI)

The firm Lake Street began coverage of IMI’s shares on 28 June. Lake Street’s Equities researchers have issued “Buy” rating while giving it the TP at $3.

IMI is hitting $1.62 during the last trading session, after decreased 1.22%.Intermolecular, Inc. has volume of 2,273 shares. Since June 29, 2017 IMI has risen 63.64% and is uptrending. IMI outperformed by 51.07% the S&P 500.

Intermolecular, Inc. engages in the development of advanced materials using high productivity combinatorial technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide.The company has $80.35 million market cap. The company's HPC platform includes Tempus processing tools, automated characterization methods, and informatics analysis software for research and development using combinatorial process systems in concert with established chemical vapor deposition, physical vapor deposition, and atomic layer deposition methods.Currently it has negative earnings. It serves various markets, including semiconductor, glass, advanced alloys, light-emitting diodes, flat-panel displays, and others.

There’s a substantial Intermolecular, Inc. (NASDAQ:IMI) news released by It’s an item titled: “Lake Street Capital Markets Starts Intermolecular (IMI) at Buy” on June 28, 2018.

Intermolecular, Inc. (NASDAQ:IMI) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.